...; Graciela Alejandra González-Cantú; Miguel Angel Herrera-Rojas; Isabel Sada-Ovalle; David Gómez-Almaguer Purpose: To evaluate the safety and efficacy of ocular cyclosporine in the prevention of the development of ocular graft versus host disease (oGVHD) in patients undergoing allogeneic hematopoietic stem...

...Moshe Mittelman; Howard S. Oster cyclosporine A Immunotherapy Myelodysplasia The arsenal of therapeutic agents for patients with myelodysplastic syndromes (MDS) has broadened over the last decade, and many MDS patients benefit today from novel agents. In patients classified as lower...

... lymphoma (SPTL) is a rare subtype of non-Hodgkin lymphoma for which a definitive therapeutic strategy has not been established yet. We report a case of chemotherapy-resistant SPTL with hemophagocytic syndrome (HPS) which was successfully treated with cyclosporine A (CsA) plus methylprednisolone (mPSL...

...Han Bing; Yan Siyi; Zhang Wei; Li Jian; Duan Minghui; Jiao Li; Wang Shujie; Zhou Daobin; Zou Nong; Zhu Tienan; Xu Ying; Zhao Yongqiang; Shen Ti Objective: To evaluate the treatment efficacy and tolerance of anti-human T lymphocyte porcine immunoglobulin (p-ALG) plus cyclosporine A (CsA) in acquired...

...Soo-Jeong Park; Chi-Wha Han; Je-Hoon Lee; Hyeon-Seok Eom; Seung-Hun Lee; Dae-Chul Jeong; Ji-Hyang Lim We describe a complete remission with cyclosporine A in a myelodysplastic syndrome (MDS) patient who had a 9-year history of nephrotic syndrome (NS) due to autoimmune nephritis. A 72-year-old woman...